Oncopeptides publishes year-end report 2021

/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on the development of therapies for difficult-to-treat hematological...

Related Keywords

Sweden ,United States ,Stockholm ,United Kingdom ,American ,Martyj Duvall ,Anders Martin ,Annika Muskantor ,Rolf Gulliksen ,Linda Holmstr ,Jakob Lindberg ,American Society Of Hematology Meeting ,Global Head Of Corporate Communications ,Nasdaq Stockholm ,Annual American Society ,Hematology Meeting ,Lancet Haematology ,Oncopeptide Leadership ,Abuse Regulation ,Securities Markets ,Global Head ,Corporate Communications ,Investor Relations ,Mid Cap ,Oncopeptides Ab ,